Chelet Bleyl
Physician Assistant · Orem, UTNPI 1821720046
Payments from drug & device makers
Across 92 payments — averaging $22.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$467
- AstraZeneca$177
- Novo Nordisk$127
- Sanofi$123
- Genentech USA, Inc.$123
- Regeneron Healthcare Solutions, Inc.$116
- plus $954 from 19 others
What the payments were for
- Food & beverage$1,99896%
- Education$894%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $467 |
| AstraZeneca | 9 | $177 |
| Novo Nordisk | 4 | $127 |
| Sanofi | 4 | $123 |
| Genentech USA, Inc. | 1 | $123 |
| Regeneron Healthcare Solutions, Inc. | 2 | $116 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $96 |
| Lilly USA, LLC | 5 | $88 |
| Organon | 5 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| Merck | 4 | $81 |
| Pfizer | 5 | $81 |
| CSL Behring | 4 | $76 |
| Galderma Laboratories, L.p. | 3 | $66 |
| Novartis | 2 | $51 |
| Pharming Healthcare, Inc. | 3 | $49 |
| Corium, LLC | 3 | $46 |
| Amgen | 2 | $35 |
| Tersera Therapeutics LLC | 1 | $22 |
| Biocryst US Sales Co., LLC | 1 | $18 |
| Kaleo, Inc. | 1 | $18 |
| Cranial Technologies, Inc | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Blueprint Medicines Corporation | 1 | $14 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,087 in reported general payments places this provider in the 80th percentile of 1,543 physician assistant providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 25 | $26,447 |
| OzempicSemaglutide | 13 | $14,621 |
| Duloxetine Hcl | 19 | $660 |
| Liothyronine Sodium | 19 | $614 |
| Bupropion XlBupropion Hcl | 20 | $469 |
| Levothyroxine Sodium | 38 | $422 |
| Rosuvastatin Calcium | 42 | $363 |
| Atorvastatin Calcium | 28 | $288 |
| Metformin Hcl ErMetformin Hcl | 29 | $273 |
| Lisinopril | 28 | $198 |
| Pantoprazole Sodium | 14 | $197 |
| Gabapentin | 12 | $183 |
| Famotidine | 11 | $162 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $132 |
| Allopurinol | 11 | $132 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $88 | $26,44725 claims |
| Novo NordiskOzempic | $127 | $14,62113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,543 physician assistant providers in Utah.
Other physician assistant in Orem
- Regan BrooksSlc$606K
- Keri HolyoakMidvale$438K
- Jill EricksonSalt Lake City$179K
- Vanessa Beard-ElyMurray$80K
- Natalie BeeSalt Lake City$63K
- Jasmin CharlesTaylorsville$46K
- Luke JenkinsWest Jordan$46K
- Chanise FrandsenSandy$31K
- Alexandra RoccoWashington Terrace$31K
- Jenna RhotonOgden$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.